Product Image

Contributor Information

  • Name Medical-Industrial Translational Research Center
  • Institute Fukushima Medical University

Tool Details

  • Tool name: MCF10A-AKTm-1 cell line
  • Alternate names: 06M09003
  • Clone: AKT1_type-02
  • Tool type: Cell Lines
  • Tool sub-type: Continuous
  • Parental cell line: MCF10A, a non-tumorigenic cell line from human mammarygland epithelium
  • Organism: Human
  • Tissue: Mammarygland epithelium
  • Cancer type: Non-tumorigenic
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Model: Mutant
  • Model description: Type-02; Type mutation: E17K; CDS mutation: c.49G>A; AA mutation: p.E17K; COSMIC Mutation ID: COSM33765
  • Application: Functional analysis of mutated genes, Drug screening
  • Description: Non-tumorigenic immortalized breast epithelial cell stably overexpressing mutant cancer-related gene, AKT1 (AKT serine/threonine kinase 1). AKT1, also referred to as protein kinase B, is a known oncogene. AKT activation relies on the PI3K pathway, and is recognized as a critical node in the pathway. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers.The E17 hotspot is the most characterized of AKT1 mutations, and has been shown to result in activation of the protein. Mutations in AKT1 have also been shown to confer resistance to allosteric kinase inhibitors in vitro.
  • Research area: Cancer; Cell biology

  • For Research Use Only

Target Details

  • Target: AKT serine/threonine kinase 1 [AKT1]
  • Target background: Gene ID: 207; References: DNA (mRNA): NM_005163.2; Protein: NP_005154.2

Application Details

  • Application: Functional analysis of mutated genes, Drug screening


  • Format: Frozen
  • Growth medium: DMEM/Ham's F-12 supplemented with 5% heat-inactivated horse serum, 10 µg/ml insulin (human, recombinant), 5 µM forskolin, 0.5 µg/ml hydrocortisone, 20 ng/ml EGF (human, recombinant), 100 U/ml penicillin, and 100 µg/ml streptomycin
  • Temperature: 37?C
  • Atmosphere: Humidified incubator with 5% CO2
  • Storage medium: CELLBANKER 2 (Zenogen pharma)
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Characterisation tests: Comprehensive gene expression analysis; Identification of cell proliferation and cellular form; Drug sensitivity tests
  • Initial handling information: Thaw the vial at 37 °C in a water bath?then seed cells into a T75 flask. Culture in a humidified Incubator at 37 ? with 5% CO2 in air. Culture medium should be changed every 2 to 3 days.
  • Cultured in antibiotics?: 100 U/ml Penicillin, and 100 µg/ml Streptomycin
  • Mycoplasma free: Yes
  • Biosafety level: 1


  • Available on request